Le Lézard
Classified in: Health
Subjects: SVY, BFA

Shatterproof and Pacira Pharmaceuticals Raise Awareness of Opioid Overprescribing


PARSIPPANY, N.J., Oct. 18, 2017 /PRNewswire/ -- Despite efforts to combat the nation's growing opioid crisis, a new research report, The United States of Non-Dependence shows Americans continue to be exposed to an exorbitant number of opioids. In fact, in 2016 alone there were enough pills prescribed for every man, woman and child in the U.S. to have 36 pills each.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/81463241-opioid-overprescribing-awareness-choices-matter/

The research, conducted by the QuintilesIMS Institute, is the most current analysis of national trends in opioid prescribing and discovered that overprescribing is posing a serious threat to our communities. In 2016 alone 3.3 billion pills were left unused by patients who had surgery, making them available for diversion or misuse. Further, the majority of patients received an opioid to manage postsurgical pain, and those given prescriptions were prescribed an average of 85 pills each, whether they needed them or not. This report continues to validate how the surgical setting has become an inadvertent gateway to the growing opioid epidemic.

Now more than ever, it is important to educate the public and empower patients to talk to their doctors about pain management options, especially in the postsurgical setting where patients can benefit from the availability of effective non-opioid options.

Shatterproof and professional athlete, Gabby Reece, have recently partnered with the Choices Matter campaign to encourage patients, caregivers and physicians to discuss postsurgical pain management, including non-opioid options, before surgery takes place. This campaign provides an opportunity to drive consideration for alternatives, which can potentially minimize or, in some cases, completely eliminate the need for opioids after surgery, therefore reducing the risk of misuse and addiction.

By educating physicians about proper opioid prescribing and alternate ways to manage pain after surgery, we're hopeful that fewer families will be devastated by this epidemic. 

The Choices Matter PSA encourages viewers to learn about non-opioid options and "pledge" to take a stand against opioid overprescribing.

For more information, visit PlanAgainstPain.com.

SOURCE Pacira Pharmaceuticals in partnership with Shatterproof


These press releases may also interest you

at 16:45
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:34
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...

at 16:30
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...

at 16:28
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...



News published on and distributed by: